Description

3-Quinolinecarboxylic Acid, 1-Cyclopropyl-6-Fluoro-1,4-Dihydro-8-Methoxy-7-[3-Methyl-4-[(Methylamino)Thioxomethyl]-1-Piperazinyl]-4-Oxo- is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is critical for the synthesis of novel fluoroquinolone antibiotics, offering a key building block for research and development in antimicrobial therapies. It is primarily required by pharmaceutical manufacturers, R&D laboratories, and fine chemical producers focused on developing next-generation antibacterial agents.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of advanced fluoroquinolone antibiotic candidates.
• Antimicrobial Research: Used in R&D for developing new antibacterial compounds with improved efficacy and spectrum of activity.
• Chemical Synthesis: Serves as a sophisticated building block for constructing complex heterocyclic molecules in medicinal chemistry.
• Process Development: Employed in scaling up and optimizing manufacturing routes for target active pharmaceutical ingredients (APIs).
• Reference Standard: Utilized as a high-purity analytical standard for quality control and method validation in pharmaceutical analysis.

Basic Information

Product Name	3-Quinolinecarboxylic Acid, 1-Cyclopropyl-6-Fluoro-1,4-Dihydro-8-Methoxy-7-[3-Methyl-4-[(Methylamino)Thioxomethyl]-1-Piperazinyl]-4-Oxo-
CAS No.	714925-36-7
Molecular Formula	C₂₀H₂₄FN₅O₄S
Molecular Weight	449.50 g/mol
Synonyms	1-Cyclopropyl-6-fluoro-8-methoxy-7-[3-methyl-4-(methylcarbamothioyl)piperazin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; Garenoxacin Intermediate; Garenoxacin Carboxylic Acid; DX-619 Carboxylic Acid; AM-1155 Intermediate; 7-(3-Methyl-4-(methylcarbamothioyl)piperazin-1-yl)-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid
EINECS	Contact for details

Quality Control

Our 3-Quinolinecarboxylic Acid derivative is manufactured under strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via IR and NMR, to ensure it meets the stringent requirements for pharmaceutical intermediates. Certificates of Analysis (COA) detailing all specifications are provided with each shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container sealed to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.